$FCAU The European car industry received a confidence

New Post Public Reply Private Reply Replies (0) Message Board
mick
161
$FCAU The European car industry received a confidence boost Wednesday as the continent's manufacturers continued to post a raft of positive first-quarter results, raising expectations that the region soon join the U.S. in returning to its precrisis record for new vehicle sales.

Fiat Chrysler Automobiles NV's reported results that beat expectations, leading to a jump in the company's stock.

Daimler AG, the maker of Mercedes-Benz cars, said quarterly net profit had doubled as sport-utility vehicle sales surged and raised its forecasts for the year. Peugeot, which during the first quarter reached an agreement to buy General Motors Co.'s European business, reported a 4.9% rise in revenue that beat expectations.

Wednesday's results come after strong showings last week from Volkswagen AG and BMW AG.

Car makers sold 14.6 million new vehicles in the EU in 2016, the highest number in almost a decade, yet the region has had a long journey back from the financial crisis and volume is still about 6% below the precrisis high set in 2007. That compares with the U.S. where auto makers sold 17.6 million vehicles in 2016, a second straight yearly record.

The European recovery has been uneven with some countries, including Germany and the U.K., passing their prerecession highs for car sales. Those on the southern edge of the continent, in particular Italy, haven't made it yet.

The first-quarter results and upbeat forecasts will help to appease an industry that has been on edge despite recent signs of improvement. Enthusiasm for incremental advances in car sales seen since early 2016 were tempered by political upheaval such as the U.K's vote to leave the EU and terror attacks across the region.

So far, car sales in the U. K.--the region's second-biggest market after Germany--have remained buoyant despite the Brexit vote and the small price rises that several companies introduced to help offset the fall in the value of the pound. The terrorist attacks didn't significantly hurt consumer confidence on the continent, while in the Netherlands the far-right populist party failed to make inroads and in France, a runoff in early May is expected to elect a centrist, pro-European president.

Fiat Chrysler reported an 11% increase in first-quarter profit as revenue advanced and the Italian-American car maker improved results in its two main markets. In the U.S., profit inched up 1% even as the company sold 6% fewer vehicles. The results cheered investors who had been expecting worse after Chief Executive Sergio Marchionne said earlier this month that the first quarter was "difficult." The car maker also confirmed its ambitious full-year targets.

The company's shares were 6.3% higher at EUR10.31 in Milan trading, the best performing auto stock in Europe.

Daimler's net profit in the three months to the end of March doubled to EUR2.7 billion ($2.94 billion). The company said revenue and operating profit would "increase significantly" this year.

Peugeot, official known as Group PSA, said revenue in the first quarter rose to EUR13.6 billion as sales of higher-margin new cars helped offset currency pressure. The company said it expects the automotive market to grow by about 1% in Europe this year.

Paris-based Peugeot is focusing on Europe with its acquisition of GM unit Opel, which will boost auto sales there by 50%, making it the region's second-largest car maker after Volkswagen.

Write to Eric Sylvers at eric.sylvers@wsj.com


(END) Dow Jones Newswires

April 26, 2017 10:20 ET (14:20 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing Insights: Man Group PLC's Position in Spectris plc

Updated Category News Views 315

Understanding Man Group PLC's Investment Position Man Group PLC, a primary player in investment management, recently announced its public interests regarding relevant securities in Spectris plc. This disclosure highlights its strategic investment and positions in the market. Key Information Disclosure As per regulatory requirements, Man Group PLC has provided essential...

Continue Reading
Coca Cola Surpasses Expectations Amidst Market Challenges

Updated Category News Views 357

Coca Cola Surpasses Expectations Amidst Market Challenges On a recent earnings announcement, The Coca Cola Company (NYSE: KO) exceeded Wall Street predictions, showcasing a resilient strategy to enhance revenue and earnings despite shifting consumer preferences. While demand for beverages has softened, Coca Cola's ability to raise prices proved beneficial, even as...

Continue Reading
Joget Enhances Application Development Using AI and Security

Updated Category News Views 86

Transforming Application Development with Joget AI The innovative Vibe Composition approach by Joget empowers enterprises to craft robust applications by utilizing trusted, composable components rather than traditional raw coding methods. This modern take on application development is encapsulated within the Joget AI Designer, making the process both efficient and secure....

Continue Reading
Gimme Credit Unveils Innovative Platform to Enhance Global Research

Updated Category News Views 215

Introducing Gimme Credit's New Client Platform Gimme Credit, a prominent independent provider of credit research and data, has recently launched a cutting-edge delivery platform. This initiative marks a significant step in the company's global expansion and innovation efforts. An Era of Growth and Technological Innovation The new platform utilizes a cloud-based...

Continue Reading
Comprehensive Overview of SCOR's Share and Voting Rights Data

Updated Category News Views 36

Understanding SCOR's Share Capital and Voting Rights In today's competitive landscape, it is crucial for companies to maintain transparency regarding their operations and shareholder information. SCOR, a notable player in the global reinsurance market, has recently provided an insightful declaration concerning its share capital and voting rights. This information...

Continue Reading